High dietary cholesterol facilitates classical conditioning of the rabbit's nictitating membrane response

Nutritional Neuroscience

Volumn 10, Issue 1-2, 2007, Pages 31-43

  Schreurs, Bernard G ^a   Smith Bell, Carrie A ^a   Darwish, Deya S ^b   Stankovic, Goran ^c   Sparks, D Larry ^c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Beta amyloid; Cholesterol; Classical conditioning; Learning; Nictitating membrane response; Rabbit

Indexed keywords

AMYLOID BETA PROTEIN; CHOLESTEROL; COPPER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONDITIONING; CONTROLLED STUDY; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MENTAL PERFORMANCE; NICTITATING MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; BODY WEIGHT; CEREBRAL CORTEX; CHOLESTEROL, DIETARY; CONDITIONING, CLASSICAL; COPPER; HIPPOCAMPUS; MALE; MODELS, ANIMAL; NICTITATING MEMBRANE; RABBITS;

NEPTUNIA; ORYCTOLAGUS CUNICULUS;

EID: 34247555415     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1080/10284150701232034     Document Type: Article

References (109)

1. Alexander, GJ and Kopeloff, LM (1971) Induced hypercholesterolemia and decrease susceptibility to seizures in experimental animals. Exp Neurol, 32, pp. 134-140.
2. Alissa, EM, Bahijri, SM, Lamb, DJ and Ferns, GAA (2004) The effects of coadministration of dietary copper and zinc supplements on atherosclerosis, antioxidant enzymes and indices of lipid peroxidation in the cholesterol-fed rabbit. Int J Exp Pathol, 85, pp. 265-275.
3. Atzmon, G., Gabriely, I., Griener, W., Davidson, D., Schechter, C. and Brazilai, N. (2002) Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci, 57, pp. M712-M715.
4. Barrientos, RM, Higgins, EA, Biedenkapp, JC, Sprunger, DB, Wright-Hardesty, KJ, Watkins, LR, Rudy, JW and Maier, SF (2006) Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging, 27, pp. 723-732.
5. Beaslely, CL, Honer, WG, von Bergmann, K., Falkai, P., Lutjohann, D. and Bayer, TA (2005) Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord, 7, pp. 449-455.
6. Bird, KD (2004) Analysis of variance via confience intervals, p. 226. Sage, London
7. Bjorkhem, I. (2002) Do oxysterols control cholesterol homeostasis?. J Clin Invest, 110, pp. 725-730.
8. Bjorkhem, I. and Meaney, S. (2004) Brain cholesterol: Long secret life behind a barrier. Arterioscler Thromb Vasc Biol, 24, pp. 1-11.
9. Brennan, FX and Tieder, JBI (2006) Centrally administered tumor necrosis tactor-α facilitates the avoidance performance of Sprague-Dawley rats. Brain Res, 1109, pp. 142-145.
10. Brennan, FX, Beck, KD and Servatius, RJ (2004) Proinflammatory cytokines differentially affect lever press avoidance acquisition in rats. Behav Brain Res, 153, pp. 351-355.
11. Buck, DL, Seager, MA and Schreurs, BG (2001) Conditioning-specific reflex modification of the rabbit (Oryctolagus cuniculus) nictitating membrane response: Generality and nature of the phenomenon. Behav Neurosci, 115, pp. 1039-1047.
12. Cao, D., Fukuchi, K., Wan, H. and Kim, H. (2006) Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging, 27, pp. 1632-1643.
13. Coleman, SR and Gormezano, I. (1971) Classical conditioning of the rabbit's (Oryctolagus cuniculus) nictitating membrane response under symmetrical CS-US interval shifts. J Comp Physiol Psychol, 77, pp. 447-455.
14. Cui, R., Iso, H., Toyoshima, H., Date, C., Yamamoto, A., Kikuchi, S., Kondo, T., Watanabe, Y., Koizumi, A., Inaba, Y., Tamakoshi, A. and JACC Study Group (2006) Serum cholesterol levels of mortality from stroke and coronary heart disease in Japanese: The JACC study. Atherosclerosis
15. Deyo, RA, Straube, KT and Disterhoft, JF (1989) Nimodipine facilitates associative learning in aging rabbits. Science, 243, pp. 809-811.
16. Dietschy, JM and Turley, SD (2001) Cholesterol metabolism in the brain. Curr Opin Lipidol, 12, pp. 105-112.
17. Dietschy, JM and Turley, SD (2004) Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res, 45, pp. 1375-1397.
18. Dufour, F., Liu, Q-Y, Gusev, P., Alkon, DL and Atzori, M. (2006) Cholesterol-enriched diet affects spatial learning and synaptic function in hippocampal synapses. Brain Res, 1103, pp. 88-98.
19. Elias, PK, Elias, MF, D'Agostino, RB, Sullivan, LM and Wolf, PA (2005) Serum cholesterol and cognitive performance in the Framingham heart study. Psychosom Med, 67, pp. 24-30.
20. Endo, Y., Nishimura, J-I and Kimura, F. (1996) Impairment of maze learning in rats following long-term glucocorticoid treatments. Neurosci Lett, 203, pp. 199-202.
21. Evans, RM, Emsley, CL, Gao, S., Sahota, A., Hall, KS, Farlow, MR and Hendrie, H. (2000) Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans. Neurology, 54, pp. 240-242.
22. Fazio, S. and Linton, MF (2001) The inflamed plaque: Cytokine production and cellular cholesterol balance in the vessel wall. Am J Cardiol, 88, pp. 12E-15E.
23. + channel inactivation, spike broadening, and after-hyperpolarization in Kvβ1.1-deficient mice with impaired learning. Learn Mem, 5, pp. 257-273.
24. Goritz, C., Mauch, DH, Nagler, K. and Pfrieger, FW (2002) Role of glial-derived cholesterol in synaptogenesis: New revelations in the synapse-glia affair. J Physiol (Paris), 96, pp. 257-263.
25. Gormezano, I. (1966) Classical conditioning. Experimental methods and instrumentation in psychology, McGraw-Hill, New York
26. Gormezano, I. and Gibbs, CM (1988) Transduction of the rabbit's nictitating membrane response. Behav Res Methods Instrum Comput, 20, pp. 18-21.
27. Gracia, KS, Mauk, MD, Weidemann, G. and Kehoe, EJ (2003) Covariation of alternative measures of responding in rabbit (Oryctolagus cuniculus) eyeblink conditioning during acquisition training and tone generalization. Behav Neurosci, 117, pp. 292-303.
28. Hartmann, T. (2001) Cholesterol, Aβ and Alzheimer's disease. Trends Neurosci, 11, pp. S45-S48.
29. Henry, PD and Bentley, KI (1981) Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest, 68, pp. 1366-1369.
30. Herz, J. and Chen, Y. (2006) Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci, 7, pp. 850-859.
31. Heverin, M., Meaney, S., Lutjohann, D., Diczfalusy, U., Wahren, J. and Bjorkhem, I. (2005) Crossing the barrier: Net flux of 27-hydroxycholesterol into the human brain. J Lipid Res, 46, pp. 1047-1052.
32. Huang, Y., Walker, KE, Hanley, F., Narula, J., Houser, SR and Tulenko, TN (2004) Cardiac systolic and diastolic dysfunction after a cholesterol-rich diet. Circulation, 109, pp. 97-102.
33. Jarvik, GP, Wijsman, EM, Kukull, WA, Schellenberg, GD and Larson, EB (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease. Neurology, 45, pp. 1092-1096.
34. Johnston, D., Christie, BR, Frick, A., Gray, R., Hoffman, DA, Schexnayder, LK, Watanabe, S. and Yuan, L-L (2003) Active dendrites, potassium channels and synaptic plasticity. Phil Trans R Soc Lond B, 358, pp. 667-674.
35. Kane, KA and Robinson, GB (1999) Effect of chronic nimodipine on spatial learning and on long-term potentiation. Behav Brain Res, 98, pp. 95-101.
36. Kaul, D. (2001) Molecular link between cholesterol, cytokines and atherosclerosis. Mol Cell Neurosci, 219, pp. 65-71.
37. Kessler, AR, Kessler, B. and Yehuda, S. (1986) In vivo modulation of brain cholesterol level and learning performance by a novel plant lipid: Indication of interactions between hippocampal-cortical cholesterol and learning. Life Sci, 38, pp. 1185-1192.
38. Kivipelto, M., Helkala, E-L, Hanninen, T., Laakso, MP, Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J. and Nissinen, A. (2001) Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology, 56, pp. 1683-1689.
39. Kolsch, H., Heun, R., Kerksiek, A., Bergmann, Kv, Maier, W. and Lutjohann, D. (2004) Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci Lett, 368, pp. 303-308.
40. Koudinov, AR and Koudinova, NV (2001) Essential role of cholesterol in synaptic plasticity and neuronal degeneration. FASEB J, 15, pp. 1858-1860.
41. Lamb, DJ, Avades, TY and Ferns, GAA (2001) Biphasic modulation of atherosclerosis induced by graded dietary copper supplementation in the cholesterol-fed rabbit. Int J Exp Pathol, 82, pp. 287-294.
42. Cao, D., Kim, H., Lester, R. and Fukuchi, K. (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol, 60, pp. 729-739.
43. Locatelli, S., Lutjohann, D., Schmidt, HH-J, Otto, C., Beisiegel, U. and von Bergmann, K. (2002) Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia. Evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol, 59, pp. 213-216.
44. Maier, SF and Watkins, LR (2003) Immune-to-central nervous system communication an its role in modulating pain and cognition: Implications for cancer and cancer treatment. Brain Behav Immun, 17, pp. S125-S131.
45. Mauch, DH, Nagler, K., Schumacher, S., Goritz, C., Muller, E-C, Otto, A. and Pfrieger, FW (2001) CNS synaptogenesis promoted by glial-derived cholesterol. Science, 294, pp. 1354-1357.
46. Miller, S. and Wehner, JM (1994) Cholesterol treatment facilitates spatial learning performance in DBA/2Ibg mice. Pharmacol Biochem Behav, 49, pp. 257-261.
47. Muldoon, MF, Ryan, CM, Matthews, KA and Manuck, SB (1997) Serum cholesterol and intellectual performance. Psychosom Med, 59, pp. 382-387.
48. Näslund, J., Haroutunian, V., Mohs, R., Davis, KL, Davies, P., Greengard, P. and Buxbaum, JD (2000) Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA, 283, pp. 1571-1577.
49. Nayler, WG (1999) Review of preclinical data of calcium channel blockers and atherosclerosis. J Cardiovasc Pharmacol, 33, pp. S7-S11.
50. Nelson, TJ, Schreurs, BG and Alkon, DL (1999) Memory storage mechanisms: GTP-binding proteins and conservation across species. Elsevier's encyclopedia of neuroscience, pp. 1138-1141. Elseiver, New York
51. Notkola, I-L, Sulkava, R., Pekkanen, J., Erkinjunti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J. and Nissinen, A. (1998) Serum total cholesterol, apolipoprotein E£4 allele, and Alzheimer's disease. Neuroepidemiology, 17, pp. 14-20.
52. O'Brien, WT, Batta, A., Tint, GS, Salen, G., Dyer, CA, Kendler, A. and Servatius, RJ (2002) Developmental sensitivity of associative learning to cholesterol synthesis inhibitors. Behav Brain Res, 129, pp. 141-152.
53. Papassotiropoulos, A., Wollmer, MA, Tsolaki, M., Brunner, F., Molyva, D., Lutjohann, D., Nitsch, R. and Hock, C. (2005) A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry, 66, pp. 940-947.
54. Pearson, HA and Peers, C. (2006) Physiological roles for amyloid β peptides. J Physiol (Lond), 575, pp. 5-10.
55. Plant, LD, Boyle, JP, Smith, IF, Peers, C. and Pearson, HA (2003) The production of amyloid β peptide is a critical requirement for the viability of central neurons. J Neurosci, 23, pp. 5531-5535.
56. + current. Neurobiol Aging, 27, pp. 1673-1683.
57. Poirier, J. (2005) Apolipoportein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging, 26, pp. 355-361.
58. Qiu, S., Korwek, KM and Weeber, EJ (2005) A fresh look at an ancient family: Emerging roles for low density lipoprotein receptors in synaptic plasticity and memory formation. Neurobiol Learn Mem, 85, pp. 16-29.
59. 2+ channel blocker amlodipine facilitates learning and memory in mice. Eur J Pharmacol, 399, pp. 57-63.
60. Rahman, SMA, Van Dam, A-M, Schultzberg, M. and Crisby, M. (2005) High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. J Neuroimmunol, 169, pp. 59-67.
61. Reitan, RM and Shipley, RE (1963) The relationship of serum cholesterol changes to psychological abilities. J Gerontol, 18, pp. 350-357.
62. Reitz, C., Luchsinger, JA, Tang, M-X, Manly, J. and Mayeux, R. (2005) Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology, 64, pp. 1378-1383.
63. Rockwood, K. (2006) Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol Scand, 114, pp. s71-s77.
64. Rockwood, K., Kirkland, S., Hogan, DB, McKnight, C., Merry, H., Verreault, R., Wolfson, C. and McDowell, I. (2002) Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol, 59, pp. 223-227.
65. Schachter, M. (1997) Calcium antagonists and atherosclerosis. Int J Cardiol, 62, pp. S9-S15.
66. Schonknecht, P., Lutjohann, D., Pantel, J., Bardenheuer, H., Hartmann, T., von Bergmann, K., Beyreuther, K. and Schroder, J. (2002) Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett, 324, pp. 83-85.
67. + channels and the regulation of neuronal excitability in the hippocampus. Mol Neurobiol, 25, pp. 51-66.
68. Schreurs, BG (2003) Classical conditioning and modification of the rabbit's (Oryctolagus cuniculus) unconditioned nictitating membrane response. Behav Cogn Neurosci Rev, 2, pp. 83-96.
69. Schreurs, BG and Alkon, DL (1990) US-US conditioning of the rabbit's nictitating membrane response: Emergence of a conditioned response without alpha conditioning. Psychobiology, 18, pp. 312-320.
70. Schreurs, BG, Oh, MM, Hirashima, C. and Alkon, DL (1995) Conditioning-specific modification of the rabbit's unconditioned nictitating membrane response. Behav Neurosci, 109, pp. 24-33.
71. Schreurs, BG, Gusev, PA, Tomsic, D., Alkon, DL and Shi, T. (1998) Intracellular correlates of acquisition and long-term memory of classical conditioning in Purkinje cell dendrites in slices of rabbit cerebellar lobule HVI. J Neurosci, 18, pp. 5498-5507.
72. Schreurs, BG, Shi, T., Pineda, SI and Buck, DL (2000) Conditioning the unconditioned response: Modification of the rabbit's (Oryctolagus cuniculus) unconditioned nictitating membrane response. J Exp Psychol Anim Behav Process, 26, pp. 144-156.
73. Schreurs, BG, Smith-Bell, CA, Lochhead, J. and Sparks, DL (2003) Cholesterol modifies classical conditioning of the rabbit (Oryctolagus cuniculus) nictitating membrane response. Behav Neurosci, 117, pp. 1220-1232.
74. Schreurs, BG, Gonzales-Joekes, J. and Smith-Bell, CA (2006) Conditioning-specific reflex modification of the rabbit (Oryctolagus cuniculus) nictitating membrane response is sensitive to context. Learn Behav, 34, pp. 315-324.
75. Seager, MA, Smith-Bell, CA and Schreurs, BG (2003) Conditioning-specific reflex modification of the rabbit (Oryctolagus cuniculus) nictitating membrane response: US intensity effects. Learn Behav, 31, pp. 292-298.
76. Servatius, RJ and Beck, KD (2003) Facilitated acquisition of the classically conditioned eyeblink response in male rats after systemic IL-1β. Integr Physiol Behav Sci, 38, pp. 169-178.
77. Shobab, LA, Hsiung, G-Y and Feldman, HH (2005) Cholesterol in Alzheimer's disease. Lancet Neurol, 4, pp. 841-852.
78. Simons, M., Keller, P., Dichgans, J. and Schulz, JB (2001) Cholesterol and Alzheimer's disease: Is there a link?. Neurology, 57, pp. 1089-1093.
79. Simons, M., Schwarzler, F., Lutjohann, D., von Bergmann, K., Beyreuther, K., Dichgans, J., Wormstall, H., Hartmann, T. and Schulz, JB (2002) Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol, 52, pp. 346-350.
80. Sooksawate, T. and Simmonds, MA (2001) Effects of membrane cholesterol on the sensitivity of the GABAA receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology, 40, pp. 178-184.
81. Sooksawate, T. and Simmonds, MA (2001) Influence of membrane cholesterol on modulation of the GABAA receptor by neuroactive steroids and other potentiators. Br J Pharmacol, 134, pp. 1303-1311.
82. Sparks, DL (1997) Coronary artery disease, hypertension, ApoE and cholesterol: A link to Alzheimer's disease. Ann NY Acad Sci, 826, pp. 128-146.
83. Sparks, DL (1997) Dietary cholesterol induces Alzheimer-like β-amyloid immunoreactivity in rabbit brain. Nutr Metab Cardiovasc Dis, 7, pp. 255-266.
84. Sparks, DL and Schreurs, BG (2003) Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci USA, 100, pp. 11065-11069.
85. Sparks, DL, Hunsaker III, JC, Scheff, SW, Kryscio, RJ, Henson, JL and Markesbery, WR (1990) Cortical senile plaques in coronary heart disease, aging and Alzheimer's disease. Neurobiol Aging, 11, pp. 601-607.
86. Sparks, DL, Scheff, SW, Hunsaker III, JC, Liu, H., Landers, T. and Gross, DR (1994) Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol, 126, pp. 88-94.
87. Sparks, DL, Lochhead, J., Horstman, D., Wagoner, T. and Martin, T. (2002) Water quality has a pronounced effect on cholesterol-induced accumulation of Alzheimer amyloid (aβ) in rabbit brain. J Alzheimers Dis, 4, pp. 523-529.
88. Sparks, DL, Connor, DJ, Sabbagh, MN, Petersen, RB, Lopez, J. and Browne, P. (2006) Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: Results of the Alzheimer's disease cholesterol-lowering treatment (ADCLT) trial. Acta Neurol Scand, 114, pp. s3-s7.
89. Sparks, DL, Friedland, R., Petanceska, S., Schreurs, BG, Shi, J., Perry, G., Smith, MA, Sharma, A., DeRosa, S., Ziolkowski, C. and Stankovic, G. (2006) Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. J Nutr Health Aging, 10, pp. 247-254.
90. Stewart, R., Russ, C., Richards, M., Brayne, C., Lovestone, S. and Mann, A. (2001) Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement Geriatr Cogn Disord, 12, pp. 251-256.
91. Thomson, LM and Sutherland, RJ (2005) Systemic administration of lipopolysaccharide and interleukin-1β have different effects on memory consolidation. Brain Res Bull, 67, pp. 24-29.
92. Tuma, PL and Hubbard, AL (2003) Transcytosis: Crossing cellular barriers. Physiol Rev, 83, pp. 871-932.
93. Upchurch, M. and Wehner, JM (1988) DBA/2Ibg mice are incapable of cholinergically-based learning in the Morris water maze. Pharmacol Biochem Behav, 29, pp. 325-329.
94. van Exel, E., de Craen, AJM, Gussekloo, J., Houx, P., der Weil, A Bootsma-van, Macfarlane, PW, Blauw, GJ and Westendorp, RGP (2002) Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol, 51, pp. 716-721.
95. Vauthey, C., de Freitas, GR, van Melle, G., Devuyst, G. and Bogousslavsky, J. (2000) Better outcome after stroke with higher serum cholesterol levels. Neurology, 54, pp. 1944-1949.
96. Voikar, V., Rauvala, H. and Ikonen, E. (2002) Cognitive deficit and development of motor impairment in a mouse model of Niemann-Pick type C disease. Behav Brain Res, 132, pp. 1-10.
97. Whitmer, RA, Sidney, S., Selby, J., Johnston, SC and Yaffe, K. (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 64, pp. 277-281.
98. Wolozin, B., Kellman, W., Celesia, GC and Siegel, G. (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol, 57, pp. 1439-1443.
99. Woodruff-Pak, DS, Chi, J., Li, Y-T, Pak, MH and Fanelli, RJ (1997) Nimodipine ameliorates impaired eyeblink classical conditioning in order rabbits in the long-delay paradigm. Neurobiol Aging, 18, pp. 641-649.
100. Wood, WG, Igbavboa, U., Exkert, GP, Johnson-Anuna, LN and Muller, WE (2005) Is hypercholesterolemia a risk factor for Alzheimer's disease. Mol Neurobiol, 31, pp. 185-192.
101. Ghosh, S., Wang, X., Das, A., Anderson, FP and Kukreja, RC (2006) Hypercholestrolemia enhances tolerance to lethal systemic hypoxia in middle-aged mice: Possible role of VEGF downregulation in brain. Mol Cell Biochem, 291, pp. 205-211.
102. Kang, J. (2005) The mechanisms and functions of activity-dependent long-term potentiation of intrinsic excitability. Rev Neurosci, 16, pp. 311-323.
103. Servatius, RJ, Shefer, S., Tint, GS, O'Brien, WT, Batta, AK and Salen, G. (1998) Relationship between abnormal cholesterol synthesis and retarded learning in rats. Metabolism, 47, pp. 878-882.
104. Yaffe, K., Barret-Connor, E., Lin, F. and Grady, D. (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol, 59, pp. 378-384.
105. Yanagisawa, K. (2003) Cholesterol and Aβ aggregation. Pharmacopsychiatry, 36, pp. S127-S129.
106. Yehuda, S. and Carasso, RL (1993) Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified α-linolenic and linoleic acids: Determination of the optimal ω3-to-ω6 ratio. Proc Natl Acad Sci USA, 90, pp. 10345-10349.
107. Yehuda, S., Rabinovitz, S. and Motofsky, DI (1998) Modulation of learning and neuronal membrane composition in the rat by essential fatty acid preparation: Time-course analysis. Neurochem Res, 23, pp. 627-634.
108. Zhang, W. and Linden, DJ (2003) The other side of the engram: Experience-driven changes in neuronal intrinsic excitability. Nat Rev Neurosci, 4, pp. 885-900.
109. Zuliani, G., Cherubini, A., Atti, AR, Ble, A., Vavalle, C., Todaro, F Di, Benedetti, C., Volpato, S., Marinescu, MG, Senin, U. and Fellin, R. (2004) Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke. J Gerentol Med Sci, 59, pp. 293-297.